

(Sharecast News) - Shield Therapeutics said on Thursday that the US Food and Drug Administration (FDA) has granted priority review to extend the indic...


(Alliance News) - London stocks remained mostly higher at midday on Thursday, as UK construction optimism sank to its lowest level in two and a half y...


(Alliance News) - Shield Therapeutics PLC on Thursday reported progress toward expanding the patient population for its oral treatment for those with ...


(Sharecast News) - Shield Therapeutics reported a sharp rise in first-half revenue on Wednesday, as sales of its oral iron therapy Accrufer accelerate...


(Alliance News) - Shield Therapeutics PLC on Thursday reported a narrowing of its half-year loss, bolstered by US sales and milestone payments globall...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday.


(Alliance News) - Shield Therapeutics PLC on Wednesday said it is on track to turn free cash flow positive by the end of the year, as the pharmaceutic...


(Alliance News) - European blue-chips opened higher on Wednesday following the agreement of a US-Japan trade deal, and as China too looks to "strength...